BR9709432A - Composto antivirais - Google Patents
Composto antiviraisInfo
- Publication number
- BR9709432A BR9709432A BR9709432A BR9709432A BR9709432A BR 9709432 A BR9709432 A BR 9709432A BR 9709432 A BR9709432 A BR 9709432A BR 9709432 A BR9709432 A BR 9709432A BR 9709432 A BR9709432 A BR 9709432A
- Authority
- BR
- Brazil
- Prior art keywords
- antiviral compounds
- antiviral
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1922496P | 1996-06-06 | 1996-06-06 | |
| PCT/US1997/008846 WO1997046235A1 (en) | 1996-06-06 | 1997-06-05 | Anti-viral compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9709432A true BR9709432A (pt) | 1999-08-10 |
Family
ID=21792091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9709432A BR9709432A (pt) | 1996-06-06 | 1997-06-05 | Composto antivirais |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5821242A (pt) |
| EP (1) | EP0938310A4 (pt) |
| JP (1) | JP2001502661A (pt) |
| KR (1) | KR20000016405A (pt) |
| CN (1) | CN1220603A (pt) |
| AU (1) | AU3286297A (pt) |
| BR (1) | BR9709432A (pt) |
| CA (1) | CA2254993A1 (pt) |
| EA (1) | EA001389B1 (pt) |
| WO (1) | WO1997046235A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5891874A (en) * | 1996-06-05 | 1999-04-06 | Eli Lilly And Company | Anti-viral compound |
| WO1998031363A1 (en) * | 1997-01-22 | 1998-07-23 | Eli Lilly And Company | Anti-viral compounds |
| JP2001513084A (ja) | 1997-02-25 | 2001-08-28 | ザ ガバメント オブ ザ ユナイテッド ステーツ オブ アメリカ，レプリゼンテッド バイ ザ セクレタリー，デパートメント オブ ヘルス アンド ヒューマン サービシズ | 逆転写酵素の非ヌクレオシド阻害剤としての置換ベンズイミダゾール |
| CA2293508A1 (en) * | 1997-06-04 | 1998-12-10 | Louis Nickolaus Jungheim | Anti-viral compounds |
| SK17482000A3 (sk) * | 1998-05-20 | 2005-03-04 | Eli Lilly And Company | Antivírusové zlúčeniny, spôsob inhibície vírusov a farmaceutický prípravok |
| EP1107961A4 (en) | 1998-08-25 | 2002-01-30 | Univ Yale | INHIBITION AND TREATMENT OF HEPATITIS B-VIRUS AND FLAVIVIRUS BY HELIOXANTHIN AND ANALOGA OF THEM |
| KR20110079783A (ko) | 2003-02-19 | 2011-07-07 | 예일 유니버시티 | 항-바이러스 뉴클레오시드 유사체 및 바이러스 감염, 특히 에이치아이브이 감염의 치료방법 |
| KR20070011451A (ko) | 2004-05-05 | 2007-01-24 | 예일 유니버시티 | 신규의 항바이러스 헬리오크산틴 유사체 |
| MX2010013019A (es) * | 2008-05-27 | 2011-03-21 | Biota Scient Management Pty Ltd | Sales antivirales. |
| PE20131351A1 (es) * | 2010-09-30 | 2013-12-04 | Boehringer Ingelheim Int | Formas en estado solido de un potente inhibidor del vch |
| US9487476B2 (en) | 2011-10-12 | 2016-11-08 | Yale University | Catechol diethers as potent anti-HIV agents |
| WO2017181317A1 (en) * | 2016-04-18 | 2017-10-26 | Eli Lilly And Company | Treatment for nonalcoholic steatohepatitis and fibrosis |
| CN109265504B (zh) * | 2018-11-08 | 2021-07-02 | 河南省科学院高新技术研究中心 | 4-氨基酸取代嘧啶核苷化合物及其药物用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4289782A (en) * | 1979-04-17 | 1981-09-15 | Eli Lilly And Company | Antiviral 1-sulfonylbenzimidazoles |
| US4401817A (en) * | 1981-04-20 | 1983-08-30 | Eli Lilly And Company | Carbonyl-substituted 1-sulfonylbenzimidazoles |
| US4420479A (en) * | 1982-04-08 | 1983-12-13 | Eli Lilly And Company | Olefinic benzimidazoles, formulations, and antiviral methods |
| US4434288A (en) * | 1982-04-08 | 1984-02-28 | Eli Lilly And Company | Preparation of substituted 1-thiazinyl or 1-thiazolyl-2-aminobenzimidazoles |
| US4492708A (en) * | 1982-09-27 | 1985-01-08 | Eli Lilly And Company | Antiviral benzimidazoles |
| JPS58188868A (ja) * | 1983-04-08 | 1983-11-04 | イ−ライ・リリ−・アンド・カンパニ− | オレフイン系ベンズイミダゾ−ル類 |
| US5216003A (en) * | 1992-01-02 | 1993-06-01 | G. D. Searle & Co. | Diacid-containing benzimidazole compounds for treatment of neurotoxic injury |
| US5545653A (en) * | 1995-06-07 | 1996-08-13 | Eli Lilly And Company | Anti-viral compounds |
| US5891874A (en) * | 1996-06-05 | 1999-04-06 | Eli Lilly And Company | Anti-viral compound |
| EP0906097A4 (en) * | 1996-06-05 | 2000-12-13 | Lilly Co Eli | ANTIVIRAL COMPOUNDS |
-
1997
- 1997-06-04 US US08/868,638 patent/US5821242A/en not_active Expired - Fee Related
- 1997-06-05 EP EP97928660A patent/EP0938310A4/en not_active Withdrawn
- 1997-06-05 CA CA002254993A patent/CA2254993A1/en not_active Abandoned
- 1997-06-05 WO PCT/US1997/008846 patent/WO1997046235A1/en not_active Application Discontinuation
- 1997-06-05 KR KR1019980709979A patent/KR20000016405A/ko not_active Application Discontinuation
- 1997-06-05 BR BR9709432A patent/BR9709432A/pt not_active Application Discontinuation
- 1997-06-05 CN CN97195112A patent/CN1220603A/zh active Pending
- 1997-06-05 EA EA199900003A patent/EA001389B1/ru not_active IP Right Cessation
- 1997-06-05 AU AU32862/97A patent/AU3286297A/en not_active Abandoned
- 1997-06-05 JP JP10500628A patent/JP2001502661A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20000016405A (ko) | 2000-03-25 |
| JP2001502661A (ja) | 2001-02-27 |
| EP0938310A4 (en) | 2001-03-21 |
| EA001389B1 (ru) | 2001-02-26 |
| AU3286297A (en) | 1998-01-05 |
| CA2254993A1 (en) | 1997-12-11 |
| CN1220603A (zh) | 1999-06-23 |
| EP0938310A1 (en) | 1999-09-01 |
| EA199900003A1 (ru) | 1999-06-24 |
| WO1997046235A1 (en) | 1997-12-11 |
| US5821242A (en) | 1998-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9709643A (pt) | Compostos antivirais | |
| ID19609A (id) | Senyawa-senyawa heterosiklik | |
| ID19403A (id) | Senyawa-senyawa heterosiklik | |
| ID16152A (id) | Senyawa-senyawa triaril | |
| ID15904A (id) | Senyawa-senyawa tiofenopirimidina | |
| PT860428E (pt) | Compostos pirimidiona | |
| IS5479A (is) | Efnasambönd | |
| IS5478A (is) | Efnasambönd | |
| IS5477A (is) | Efnasambönd | |
| ID22850A (id) | Senyawa-senyawa pirazina | |
| ID19476A (id) | Senyawa piridilpirol | |
| NO994877D0 (no) | Kalsilytiske forbindelser | |
| DE69716924D1 (de) | Phosphonat-nukleotid-verbindungen | |
| ID20323A (id) | Senyawa-senyawa triazinilaminostilbena | |
| ID18685A (id) | Senyawa trisiklik tersubstitusi | |
| NO20005795D0 (no) | Antivirale forbindelser | |
| EE9900448A (et) | Ühendid | |
| BR9705635A (pt) | Compostos | |
| ID19490A (id) | Kombinasi-kombinasi antiviral | |
| BR9709432A (pt) | Composto antivirais | |
| DK0923594T3 (da) | Bromotiacumicinforbindelser | |
| BR9709528A (pt) | Compostos antivirais | |
| DE69709659D1 (de) | Halopropargyl-einschlussverbindungen | |
| EE9900475A (et) | Ühendid | |
| IS5323A (is) | Efnasambönd |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |